A clinical prediction model for infusion-related reactions to rituximab in patients with B cell lymphomas
Crossref DOI link: https://doi.org/10.1007/s11096-017-0429-3
Published Online: 2017-01-31
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hayama, Tatsuya
Miura, Katsuhiro
Uchiike, Akihiro
Nakagawa, Masaru
Tsutsumi, Daisuke
Sakagami, Masashi
Yoshida, Yoshikazu
Takei, Masami
License valid from 2017-01-31